Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Netuka

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 28, 2025
Understanding Platelet Activation in the Aeson Bioprosthetic Total Artificial Heart: Insights From Aspirin Treatment and OutcomesDavid M Smadja, Joseph Roux de Bezieux, Christophe Peronino, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 18, 2019
2019 EACTS Expert Consensus on long-term mechanical circulatory supportEvgenij V Potapov, Christiaan Antonides, Maria G Crespo-Leiro, et al.
Thrombosis and Haemostasis|July 21, 2020
Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis PreservationDavid M Smadja, Richard Chocron, Elisa Rossi, et al.
JACC. Heart Failure|November 19, 2025
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 TrialJason N Katz, Jean M Connors, Francis D Pagani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2022
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand FactorBastien Poitier, Richard Chocron, Christophe Peronino, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2026
Impact of partial- to full-support escalation with microaxial flow pumps prior to durable left ventricular assist device implantationDaniel Lewin, Gaik Nersesian, Sebastian V Rojas, et al.
JAMA Cardiology|January 8, 2025
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical TrialFinn Gustafsson, Nir Uriel, Ivan Netuka, et al.
JACC. Heart Failure|April 10, 2025
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device TherapyFrancis D Pagani, Ivan Netuka, Ulrich P Jorde, et al.
Journal of the American College of Cardiology|August 27, 2025
Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry AnalysisGuglielmo Gallone, Luca Baldetti, Kevin M Veen, et al.
European Heart Journal|November 9, 2025
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trialJean M Connors, Finn Gustafsson, Nir Uriel, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 28, 2025
Understanding Platelet Activation in the Aeson Bioprosthetic Total Artificial Heart: Insights From Aspirin Treatment and OutcomesDavid M Smadja, Joseph Roux de Bezieux, Christophe Peronino, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 18, 2019
2019 EACTS Expert Consensus on long-term mechanical circulatory supportEvgenij V Potapov, Christiaan Antonides, Maria G Crespo-Leiro, et al.
Thrombosis and Haemostasis|July 21, 2020
Autoregulation of Pulsatile Bioprosthetic Total Artificial Heart is Involved in Endothelial Homeostasis PreservationDavid M Smadja, Richard Chocron, Elisa Rossi, et al.
JACC. Heart Failure|November 19, 2025
Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 TrialJason N Katz, Jean M Connors, Francis D Pagani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2022
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand FactorBastien Poitier, Richard Chocron, Christophe Peronino, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2026
Impact of partial- to full-support escalation with microaxial flow pumps prior to durable left ventricular assist device implantationDaniel Lewin, Gaik Nersesian, Sebastian V Rojas, et al.
JAMA Cardiology|January 8, 2025
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical TrialFinn Gustafsson, Nir Uriel, Ivan Netuka, et al.
JACC. Heart Failure|April 10, 2025
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device TherapyFrancis D Pagani, Ivan Netuka, Ulrich P Jorde, et al.
Journal of the American College of Cardiology|August 27, 2025
Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry AnalysisGuglielmo Gallone, Luca Baldetti, Kevin M Veen, et al.
European Heart Journal|November 9, 2025
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trialJean M Connors, Finn Gustafsson, Nir Uriel, et al.
Pageof 13